BioCentury
ARTICLE | Company News

AbCheck, Pierre Fabre deal

April 7, 2014 7:00 AM UTC

AbCheck will use its AbSieve discovery platform to discover antibodies against undisclosed targets from Pierre Fabre. AbCheck will receive discovery fees and is eligible for milestones. Pierre Fabre w...